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The binding of D-[3H]aspartate to sections of rat brain was examined in an autoradiographic assay. Binding was entirely dependent on the 
presence of sodium ions, but not chloride ions, and was optimal at 2 °C. D-Aspartate bound rapidly, reached equilibrium within 20 min and 
remained stable for 45 rain. The rate of dissociation was relatively rapid with a tl/2 of 56 s, but was not as fast as anticipated, perhaps because 
of some sequestration of ligand. Binding had a K d of 6.8 + 1.2/~M and a Bma x of 49.4 + 8.6 pmol/mg protein. The high Bm~ , value may further 
indicate some sequestration of D-aspartate. L-Glutamate, unlabeled D-aspartate, and D.L-threo-hydroxyaspartate, a potent inhibitor of 
synaptosomal uptake, each competed for D-[3H]aspartate binding with ICs0s of 7.0 _+ 4.3/zM, 5.4 + 1.5/~M, and 2.5 + 1.0 aM, respectively. 
N-methyl-D-aspartate (NMDA), quisqualate, and kainate had no affinity for this site. The regional distribution of D-aspartate binding sites 
was unique and did not conform to the distribution of neuronal uptake sites described by others. Striatal D-aspartate binding was unaffected 
by unilateral decortication or striatal quinolinic acid lesions. In contrast, binding to NMDA, quisqualate, and kainate receptors was reduced 
by 80-90% by quinolinate lesions of the striatum. The results of D-aspartate binding after lesions strongly suggest that this site is not associated 
with either lesioned glutamatergic afferents or intrinsic neurons of the striatum; it may be associated with glia. 
INTRODUCTION 
It is general ly  bel ieved that the synaptic actions of 
g lu tamate  and aspar ta te  are te rminated  when these 
exci tatory amino acids are removed  from the synaptic 
cleft by a high-affinity uptake system 18. High-affinity 
uptake  mechanisms for exci tatory amino acids are found 
in both neurons and glia, but  in crude homogenate  
prepara t ions  uptake is predominant ly  associated with 
neuronal  synaptosomes 18. In contrast ,  glial uptake  of 
L-glutamate or  D-aspartate may predomina te  in pr imary 
cell cultures or  wel l-preserved slices of  cerebel lum TM 
14,28,36 
Synaptosomal  uptake  of t r i t ia ted L-glutamate,  L-aspar- 
tate or  D-aspartate can be used as a marke r  of  the relative 
density of g lu tamate  or  aspar ta te  nerve terminals 17"37. 
Similarly,  in fresh slices of tissue from hippocampus or 
forebrain,  neuronal  uptake  of labeled L-glutamate,  L- 
aspar ta te ,  or  D-aspartate can be demons t ra ted  16'31. When  
putat ive g lu tamate  or  aspar ta te  pathways are lesioned, a 
subequent  decrease in uptake is seen in the terminal  
fields of  those pathways in both synaptosomal  and tissue 
slice prepara t ions  (For  review see Fonnum18). In this 
way, uptake  may be used to map putat ive aspartate  or 
g lu tamate  pathways and provides a way to assess the 
integri ty of these pathways after lesions. 
In recent  years,  there  has been interest  in examining 
the roles of exci tatory amino acids in human neurological  
diseases 15'21. Since high-affinity sod ium-dependen t  up- 
take is one of the few relat ively specific markers  for 
excitatory amino acid neurons,  there  has been an effort 
to apply this technique to the study of  human postmor-  
tem tissue. Unfor tunate ly ,  studies in rat  brain have 
indicated that freezing results in a 50-80% decrease in 
uptake activity compared  to fresh tissue 22'29'3° and 
pro longed freezing results in a fur ther  decrement  of 
uptake.  Several  laborator ies  have repor ted  that sodium- 
dependent  D-aspartate or  L-glutamate binding has several  
characteristics consistent with an uptake  site 2'9'32. Sub- 
sequently,  a number  of investigators examined sodium- 
dependent  D-aspartate or  L-glutamate binding in post- 
mor tem human brains,  since it was felt that  this repre-  
sented a more  suitable and stable marke r  for the uptake 
site 5'8"9"24'27. However ,  lesion studies have suggested that  
at least 40% of  sod ium-dependen t  L-glutamate binding is 
associated with intrinsic neurons 32, and not  with lesioned 
glutamatergic afferent terminals.  More  recently,  Danbol t  
and Storm-Mathisen 12, have demons t ra ted  that  sodium- 
dependent  D-aspartate 'b inding '  in homogena tes  actually 
represents  sequestrat ion into m e m b r a n e - b o u n d e d  sac- 
cules and 'does not  represent  binding to the t ranspor t  
c a r r i e r . . . '  It would therefore  appear  that  sodium- 
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d e p e n d e n t  D-aspar ta te  b inding  in h o m o g e n a t e s  is no t  a 
re l i ab le  m a r k e r  o f  u p t a k e  sites. 
T h e  p r e sen t  s tudy was u n d e r t a k e n  to charac te r ize  
s o d i u m - d e p e n d e n t  D-aspar ta te  b ind ing  in an au to rad io -  
g raph ic  assay and to d e t e r m i n e  its suitabil i ty as a m a r k e r  
for  p re synap t i c  n e u r o n a l  u p t a k e  sites. 
MATERIALS AND METHODS 
Materials 
D-[3H]Aspartic acid (sp. act. 26 Ci/mmoi), L-[3H]glutamic acid (59 
Ci/mmol) and [3H]kainic acid were obtained from Amersham 
(Arlington Heights, IL, U.S.A.). D.L-[aH]-a-Amino-3-hydroxy- 
5-methyl-4-isoxazolepropionic acid (AMPA) was obtained from 
New England Nuclear (Boston, MA, U.S.A.). N-methyl-D- 
aspartate and quisqualate were obtained from Cambridge Research 
Biochemicals (Valley Stream, NY, U.S.A.). D.L-threo-fl-hydroxya- 
sparticacid was obtained from Caibiochem (San Diego, CA, 
U.S.A.). All other chemicals were obtained from Sigma. 
Les/ons 
Cortical ablations. Male Sprague-Dawley rats (175-250 g) were 
anesthetized with xylazine and ketamine, and their scalps were 
incised and retracted. Using a dental drill, a rectangular flap of skull 
from about 3 mm posterior to about 6 mm anterior to bregma and 
from 2 mm lateral to the mid-line to the lateral edge of the calvarium 
was removed. The underlying cortex was removed by aspiration, 
and cortex lateral to the opening in the skull was undercut with a 
suture needle. After a survival time of one week, the animals were 
killed by decapitation, and their brains quickly removed and 
processed for autoradiography. 
Striatal lesions. Male Sprague-Dawley rats (200-230 g) were 
anesthetized with nembutal (50 mg/kg) and were positioned in a 
Kopf stereotaxic frame. Unilateral striatal lesions were made with 
quinolinate at a dose of 60 nmol at uniform stereotaxic coordinates 
(1 mm anterior to bregma, 2.5 mm lateral to bregma, 5 mm deep 
from the cortical surface). Quinolinate was dissolved in 0.1 M 
phosphate buffer adjusted to pH 7.4 and injected in a small volume 
(0.5-1.0/tl) via a Hamilton syringe over a period of 8 min. The 
syringe was left in position for another 5 min prior to removal. After 
3 months, the animals were killed and the brains removed and 
processed for autoradiography. 
Tissue preparation 
After decapitation, brains were quickly removed, mounted on 
cryotome pedestals with Lipshaw embedding matrix, and were 
frozen under powdered dry ice. Twenty-/~m sections were cut on a 
Lipshaw cryostat and thaw-mounted onto gelatin-coated slides, then 
allowed to dry at room temperature. Sections were either used 
immediately or stored for less than 24 h at -20 °C. Prior to assay, 
sections were pre-washed for 30 min at 2 °C in 50 mM Tris-acetate 
buffer (pH 7.20) in order to remove endogenous free excitatory 
amino acids. This procedure does not completely remove excitatory 
amino acids, but harsher treatments damage the mounted tissue. 
Sections were blown dry under a stream of room temperature air. 
A utoradiography 
o-Aspartate. In the 'standard' D-aspartate autoradiographic assay, 
slide-mounted tissue sections were incubated for 45 rain at 2 °C in 
50 mM Tris-acetate buffer (pH 7.40) containing 150 mM sodium 
acetate (NaAc) in the presence of 90-500 nM D-[3H]aspartate. In 
saturation studies, the concentration of D-aspartate ranged from 100 
nM to 100/~M. In studies examining the association and dissociation 
of binding, the D-aspartate concentration was 100 nM; in compe- 
tition studies and studies examining the effect of sodium on binding, 
the D-aspartate concentration was 500 nM. In experiments exam- 
ining the sodium-dependence of binding, sodium was added as 
either the chloride or acetate salt. To control for the effects of 
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increased osmolality in the presence of sodium salts, binding was 
also performed in 50 mM Tris-acetate buffer containing 300 mM 
sucrose or 150 mM choline chloride or 150 mM potassium acetate. 
Non-specific binding was defined by 500 #M O.L-threo-hydroxy- 
aspartic acid. Non-specific binding represented approx. 30% of total 
binding at a D-aspartate concentration of 100 nM. 
'Sodium-dependent' glutamate binding. L-[3H]Glutamate . binding 
was determined in 50 mM Tris-acetate buffer containing 150 mM 
NaC1 or 150 mM NaAc. In the case of glutamate binding in the 
presence of NaCI, no other drugs were included in the incubation, 
and the 'blank' was determined with 1 mM unlabeled glutamate. 
When glutamate binding was measured in the presence of NaAc, 
100/~M NMDA, 1 pM quisqualic acid, and 1 #M kainic acid were 
included in the incubation. Under these conditions, 500 pM 
D.L-threo-hydroxyaspartic acid served as a blank. These assays were 
otherwise identical to the sodium-dependent D-aspartate binding 
assay. 
Receptor binding. Glutamate binding to the NMDA receptor was 
determined in 50 mM Tris-acetate buffer (pH 7.2) in the presence 
of 1/~M quisqualic acid and 1 pM kainic acid. Non-specific binding 
was defined as binding in the presence of 1 mM NMDA. 
Quisqualate receptors were measured with [3H]AMPA binding in 50 
mM Tris-HCl buffer containing 2.5 mM CaC12 and 100 mM 
potassium thiocyanate (KSCN). AMPA binding in the presence of 
1 mM unlabeled glutamate defined non-specific binding. Kainate 
receptors were assayed with [3H]-a-kainate in 50 mM Tris-acetate 
buffer (pH 7.20) using 1 mM unlabeled glutamate to define 
non-specific binding. For all receptor assays, binding was performed 
at 2 °C with an incubation period of 45 min. 
For all assays, after the incubation, sections were rinsed quickly 
3 times with cold buffer, and then rinsed with cold 2.5% (v/v) 
glutaraldehyde in acetone. Sections were then blown-dry with warm 
air. The rinse and drying procedure took no more than 10 s. Dried 
sections were placed in X-ray cassettes with appropriate radioactive 
standards and apposed to Hyperfilm (Amersham). The film was 
exposed to the tissue sections for 14-21 days at 4 °C and then 
developed, fixed, and dried. Autoradiograms were analyzed using 
an MCID image processing system (Imaging Research, St. Catha- 
rine's, Ont., Canada). All data presented were analyzed from 
autoradiographic images. 
IC50 values were determined by logit transformation. Statistical 
analysis of lesion-induced changes in binding were determined by 
paired t-tests. 
RESULTS 
Binding characteristics of  o-aspartate 
T h e  b inding  of  500 n M  D-aspar ta te  was ent i re ly  
d e p e n d e n t  on  the  p r e sence  o f  s o d i u m  ions  (Fig.  l a ) .  No  
signif icant  specif ic  b ind ing  was found  in the  absence  o f  
sodium.  Osmola l i t y  a lone  could  no t  expla in  the  effects  o f  
sod ium since unde r  sod ium- f r ee  condi t ions ,  t he re  was 
min ima l  specific b inding  in 300 m M  sucrose ,  150 m M  
chol ine  ch lor ide  o r  150 m M  po ta s s ium ace ta te .  A 
doub le - r ec ip roca l  ( L i n e w e a v e r - B u r k e )  p lo t  of  D-aspar- 
ta te  b inding versus  sod ium c o n c e n t r a t i o n  y ie lded  a 
s t raight  l ine wi th  a co r re la t ion  coef f ic ien t  of  0.99 (Fig. 
lb ) .  Resu l t s  were  ident ica l  w h e n  sod ium was added  as 
e i the r  the  ace ta te  salt  o r  the  ch lor ide  salt.  This  suggests  
that  a single sod ium ion is b o u n d  for  each  D-aspar ta te  
molecu le .  
E x a m i n a t i o n  of  the  effects  o f  t e m p e r a t u r e  on D- 
aspar ta te  b inding did no t  revea l  any t e m p e r a t u r e  depen -  
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Fig. 1. Panel a: histograms demonstrating sodium-dependence of D-aspartate binding. Bars represent specific binding + S.E.M. (n = 3). Sodium 
was added as sodium acetate salt. No specific binding was detected in the absence of sodium ions. D-[3H]Aspartate concentration was 500 nM. 
Panel b: double-reciprocal plot of o-aspartate binding vs sodium concentration. Sodium was added as acetate salt, but identical results were 
obtained with NaC1. Points represent mean + S.E.M. of specific binding from 3 animals. The S.E.M. was smaller than the size of the point 
in cases where no error bars are seen. The plot demonstrates a linear relationship between 1/B and 1/[Na] (r = 0.99). 
dence (data not shown). However, at 2 °C, binding was 
much more reproducible; binding at higher temperatures 
revealed a patchy, smeared binding artifact. 
Kinetic experiments indicated that o-aspartate bound 
to tissue sections rapidly, reaching equilibrium within 20 
min and remaining stable for at least 45 min (Fig. 2). 
After a 45-min incubation, when individual tissue sec- 
tions at equilibrium were subjected to 'infinite dilution' 
by placement in 800 ml of ice-cold 50 mM Tris-acetate 
buffer, binding dissociated rapidly, with a t,/z of 56 s. A 
plot of In (B/Bo) versus time yielded a biphasic curve with 
an initial, more rapid rate of dissociation followed by a 
slowing of the dissociation rate (data not shown). An 
estimate of k_~ was made by measuring the slope of the 
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Fig. 2. Association and dissociation of D-aspartate binding. Points 
represent mean + S.E.M. of specific binding (n = 3). The S.E.M. 
was smaller than the size of the point in cases where no error bars 
are seen. D-[3H]Aspartate concentration was 100 nM. D-Aspartate 
binds rapidly and reaches equilibrium within 20 min. When tissue 
sections at equilibrium were placed in 800 ml of cold buffer ('infinite 
dilution') binding dissociated with a t~ of 56 s. 
initial portion of this plot and yielded a k_l = 0.75 min -1. 
Using this value, k+l was determined to be 3.68 × 106 
M -1 min -1. The ratio k_Jk+l = 0.20 ~M. 
In saturation experiments, using o-aspartate concen- 
trations from 100 nM to 100~M, a K d of 6.8 + 1.2 HM was 
determined in striatum. Scatchard plots yielded a Bma x of 
49.4 + 8.6 pmol/mg protein (Fig. 3). The Hill coefficient 
was 0.79 + 0.07, and was not significantly less than unity. 
Because of previous reports that D-aspartate 'binding' 
in homogenate preparations was disrupted by freezing 
and thawing prior to assay ~2, this was examined in the 
autoradiographic assay. Sections prepared in standard 
fashion were assayed in parallel with sections which had 
received 4 additional freeze-thaw cycles. Binding to 
sections prepared in the standard manner (0.56 + 0.05 
pmol/mg protein) was not significantly different than 
binding in tissue sections which had undergone repeated 
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Fig. 3. Representative saturation curve of D-[3H]aspartate binding 
in striatum. Points represent specific binding. Inset: Scatchard plot 
of saturation data. Mean K a = 6.8 + 1.2/~M and Bma x = 49.4 _+ 
8.6 pmol/mg protein (n = 3). 
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freeze-thaw cycles (0.56 + 0.07 pmol/mg protein). 
Pharmacological specificity of o-aspartate binding 
Of the compounds tested, the high-affinity uptake 
blocker D,L-threo-hydroxyaspartic acid 1 was the most 
potent competitor for o-aspartate binding sites, with an 
ICs0 of 2.5 + 1.0 btM (Fig. 4). The Hill coefficient of this 
compound, 0.66 + 0.08, was significantly less than 1 (P 
< 0.05). L-Glutamate competed for o-aspartate binding 
sites with an ICso of 7.0 + 4.3/~M and a Hill coefficient 
of 0.88 + 0.11. Unlabeled o-aspartate competition for 
o-[3H]aspartate binding sites gave an IC50 of 5.4 _+ 1.5 
/~M and a Hill coefficient of 0.79 _+ 0.07. The Hill 
coefficients of unlabeled D-aspartate and L-glutamate did 
not significantly differ from unity. 
The receptor-specific compounds, NMDA (300/~M), 
quisqualate (300 /.tM) and kainate (100 /~M), did not 
significantly displace D-aspartate binding. The anion 
blocker 4-acetamido-4"-isothiocyanostilbene-2,2"-disulfo- 
nic acid (SITS), at a concentration of 100/~M, did not 
compete for o-aspartate binding. Similarly, 10 /~M L- 
cystine, which has been reported to inhibit chloride- 
dependent sodium-independent glutamate 'binding '23, 
had no effect on o-aspartate binding. 
Regional distribution of o-aspartate binding 
Sodium-dependent D-aspartate binding had a unique 
distribution in the rat brain (Fig. 5) which was unlike 
binding to NMDA, quisqualate, or kainate receptors 2°'25. 
The highest levels of binding were found in the cerebellar 
molecular layer, followed by lateral septum, entorhinal 
cortex, and dentate gyrus of the hippocampal formation. 
Overall, binding in forebrain was rather uniform, with 
relatively little regional variation, as compared with the 
distribution of excitatory amino acid receptors. Within 
the neocortex, lowest levels of binding were found in 
layer 1. There was relatively little lamination of binding 
in the hippocampus (Fig. 6), in contrast to binding to 
NMDA, quisqualate, and kainate receptors 2°'25. In the 
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basal ganglia, there was less binding in globus pallidus 
than in caudate-putamen, but this difference was less 
than that seen with receptor binding. 
The binding of L-Jail]glutamate in Tris-buffer contain- 
ing 150 mM NaAc, 100/~M NMDA, 1/~M quisqualate, 
and 1 /~M kainate, produced very similar regional 
distribution to that seen with D-aspartate binding (Fig. 5). 
Binding of L-glutamate in the presence of 150 mM NaC1, 
in the absence of receptor-specific compounds, resulted 
in a distinct regional distribution which was similar to the 
combined distributions of NMDA, quisqualate, and 
kainate receptors, as well as o-aspartate sites. 
Effects of lesions on binding 
In an effort to determine the synaptic localization of 
o-aspartate binding sites, binding was examined after 
unilateral decortications or striatal quinolinate lesions 
(Fig. 7). Following unilateral frontoparietal lesions, 
striatal o-aspartate binding was examined ipsilateral and 
contralateral to the lesion by means of saturation studies. 
Striatal binding ipsilateral to the lesion (Kd = 6.82 _+ 0.86 
¢tM; Bm~ = 50.2 _+ 7.0) did not differ from binding 
contralateral to the lesion (K d = 6.77 +-1.19/~M; Bm~x 
-- 49.4 + 8.6). Similarly, binding to NMDA, quisqualate, 
and kainate receptors was not significantly changed by 
unilateral decortication (Table I). Glutamate binding in 
the presence of NaC1 (without receptor-specific drugs) 
and glutamate binding in the presence of NaAc (con- 
taining NMDA, quisqualate, and kainate) were un- 
changed by decortication. 
After striatal quinolinate lesions, o-aspartate binding 
was unchanged and equal to that contralateral to the 
lesion (Table I). Similarly, L-glutamate binding in the 
presence of NaAc and receptor-specific drugs was un- 
affected by the quinolinate lesions (data not shown). In 
contrast, binding to NMDA, quisqualate, and kainate 
receptors was reduced by 80-90% in the region of the 
lesion. Binding of L-glutamate in the presence of NaCl 
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Fig. 4. Competition curves of L-glutamate (L-GLU), O,L-threo-hydroxyaspartic acid (tHA) and unlabeled o-aspartate (D-ASP). Points represent 
mean _+ S.E.M. of percent control binding in absence of competing drugs (n = 3). The S.E.M. was smaller than the size of the point in cases 
where no error bars are seen. The Hill coefficient of tHA was significantly less than 1 (0,66 + 0.08). 
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Fig. 5. Left panel: the regional distribution of D-aspartate binding in a horizontal section of rat brain. Note the high concentration of binding 
sites in the cerebellar molecular layer, and the lower level and relatively uniform distribution of binding sites in forebrain. There is very little 
binding in layer I of cortex. Right panel: regional distribution of L-glutamate binding sites assayed in the presence of 150 mM Na-acetate, 100 
/~M NMDA, 1/zM quisqualate, and 1/~M kainate. The distribution of L-glutamate binding sites under these conditions is similar to that of 
D-aspartate sites. 
reduced by an average of 61% in the region of the lesion, 
in termedia te  between the loss of receptors  and lack of 
change in the aspar ta te  binding. 
In summary,  o-aspar ta te  binding was unaffected by 
either decort icat ion or quinol inate  lesions. L-Glutamate 
binding in the presence of N a A c  behaves  identically. 
Binding to receptors  was unchanged by decor t icat ion and 
was severely decreased by striatal  lesions. Glu tamate  
Fig. 6. Left panel: D-aspartate binding to hippocampus. Right panel: glutamate binding to NMDA receptors in the presence of quisqualate 
and kainate. The distribution of D-aspartate binding sites is much more uniform than that of NMDA receptors. 
315 
Fig. 7. Autoradiograms of D-[3H]aspartate binding (top), L-glutamate binding in 150 mM NaCI without NMDA, quisqualate, or kainate to 
block l"eceptor binding (center) and L-glutamate binding to NMDA receptors (bottom) in rats which had received unilateral decortications (left) 
or unilateral striatal quinolinic acid lesions (right). D-Aspartate binding was unaffected by decortication or QA lesion (Table I). Binding to 
NMDA receptors was reduced by 92 _+ 1% after QA lesions. The reduction in L-glutamate binding in NaCI in the QA lesion was intermediate 
between the profound loss of NMDA receptors and the unchanged D-aspartate binding (see text). 
TABLE I 
Effects of  lesions on Na+-dependent o-[3H]aspartate binding, L-[3H]glutamate binding in the presence of  NaCI and L-[3H]glutamate binding to 
NMDA receptors in striatum 
Binding assays were performed as described in text. D-[3H]Aspartate concentration was 96 nM and L-[3H]glutamate concentration was 28 nM. 
Values represent mean + S.E.M. (n = 3) and are expressed in pmoi/mg protein (ipsi: ipsilateral; contra: contralateral). 
Lesion o-[3 H]aspartate L-[3 H]glutamate/Na CI L-[3 H]glutamate/NM DA 
ipsi contra ipsi contra ipsi contra 
Decortication 0.84 _+ 0.08 0.84 + 0.10 0.94 _+ 0.04 0.86 _+ 0.09 0.28 -+ 0.02 0.32 + 0.02 
Striatal 0.67 _+ 0.05 0.65 + 0.06 0.25 _+ 0.02** 0.65 + 0.01 0.02 + 0.002* 0.23 _+ 0.04 
*P < 0.05, **P < 0.02 by paired t-test, compared to contralateral striatum. 
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binding in the presence of NaCI was unaffected by 
decortication and reduced by an intermediate amount in 
quinolinate-lesioned striata. 
DISCUSSION 
Quantitative autoradiography of sodium-dependent 
D-aspartate binding has been described previously 26, and 
has recently been applied to the study of human 
pos tmor tem tissue 4"7'1°. However, detailed characteriza- 
tion of this autoradiographic binding site has not been 
reported, and evidence that it represents the neuronal 
uptake carrier is lacking. 
Characteristics of o-aspartate binding 
In our autoradiographic assay, D-aspartate binding was 
entirely dependent on the presence of sodium ions and a 
double reciprocal plot of binding versus sodium ion 
concentration suggested that one sodium ion was bound 
with each D-aspartate molecule. This finding is consistent 
with previous kinetic modeling of uptake systems 3'6. In 
contrast, Danbolt and Storm-Mathisen 11 provided evi- 
dence that in homogenates, the ratio of sodium ions to 
D-aspartate was 2. The fact that binding was the same in 
NaCI and in NaAc, together with the fact that choline 
chloride did not increase binding, suggests that chloride 
ions exert no effect on binding. The enhanced binding in 
the presence of sodium salts was not simply due to 
increased osmolality since binding was not enhanced by 
increasing the osmolality with sucrose, choline chloride 
or potassium acetate. 
Sodium-independent binding of D-aspartate has been 
reported previously, and has been used to measure 
binding to NMDA receptor sites 19. Sodium-independent 
binding was not detected in our assay and 300 pM 
NMDA had no effect on the sodium-dependent binding 
of D-aspartate. 
Kinetic experiments indicated that D-aspartate bound 
to tissue sections rapidly, reached equilibrium within 20 
min and remained stable for at least 45 min. The 
dissociation of D-aspartate from its binding site appeared 
to be biphasic and slower than expected. Because of this, 
the ratio k_Jk+~ gave a K d of 0.20pM, 20-fold lower than 
the K d determined from saturation studies. The reason 
for this relatively slow rate of dissociation is unclear, but 
it may be related to sequestration of D-aspartate as seen 
in homogenates 12. The discrepancy between the Kd 
determined kinetically and by saturation studies with 
Scatchard analysis could also be explained by multiple 
binding sites or non-equilibrium conditions. However, 
this latter explanation appears unlikely since association 
studies (Fig. 2) indicate that binding was at equilibrium. 
Unlike membrane preparations in which the seques- 
tration process was disrupted by freezing and thawing ~2, 
autoradiographic binding of D-aspartate was unaffected 
by this treatment. Furthermore, unlike the membrane 
translocation scheme proposed by Danbolt and Storm- 
Mathisen 12, D-aspartate binding was not temperature- 
dependent. Considering the differences in sodium-depen- 
dence, temperature-dependence, and sensitivity to freez- 
ing and thawing, it is likely that sodium-dependent 
D-aspartate binding in homogenates and in autoradio- 
graphic assays represents two distinct processes. 
Saturation analysis of sodium-dependent D-aspartate 
binding to tissue sections yielded a linear Scatchard plot 
with an affinity in the lower micromolar range, similar to 
the affinity of D-aspartate for the uptake site ~'6. The Hill 
coefficient of D-aspartate binding was not significantly 
different from unity, suggesting that D-aspartate was 
interacting with a single class of sites. The Bm~ (50 
pmol/mg protein) in the current study was approx. 5-fold 
lower than the Bmax reported for sodium-dependent 
L-glutamate and D-aspartate 'binding' in homogenate 
preparations 12'32, consistent with the hypothesis that 
'binding' in homogenate preparations is largely due to 
sequestration. Although the Bma x reported here is lower 
than in some homogenate binding studies, it is neverthe- 
less quite high relative to receptor numbers 2°'25. Together 
with the relatively slow, biphasic nature of o-aspartate 
dissociation, this may indicate that there was some 
sequestration of ligand in our assay. Thus, the apparent 
nma x in our studies may have been an over-estimate of 
the actual number of binding sites. 
Pharmacological specificity 
In our autoradiographic assay, the pharmacological 
specificity of D-aspartate binding was similar to that of 
neuronal uptake sites 1'6, although it should be noted that 
a limited number of compounds were tested in the 
current study. Similar to the uptake site, the D-aspartate 
binding site had a high-affinity for L-glutamate 1'6. D, 
L-threo-hydroxyaspartic acid is a potent inhibitor of 
neuronal excitatory amino acid uptake 1"6 and it inhibited 
the binding of D-aspartate with high affinity, although it 
produced a somewhat shallow competition curve and a 
Hill coefficient of 0.66. The low Hill coefficient may 
indicate that D.L-threo-hydroxyaspartic acid is interacting 
with multiple sites, or that there is some degree of 
negative cooperativity in this system. However, a more 
likely explanation is that the D- and L-isomers of this 
compound have different affinities for the D-aspartate 
binding site. NMDA, quisqualate, and kainate had little 
affinity for this binding site, even at high concentrations. 
The anion blocker SITS inhibits sodium-independent, 
chloride-dependent glial uptake of glutamate 35, but had 
no effect in our assay. L-Cystine can be used to 
distinguish sodium-indepenent, chloride-dependent glu- 
tamate sequestration from glutamate binding 23. This 
compound had no effect on D-aspartate binding. Thus, it 
is unlikely that D-aspartate binding is associated with 
chloride-dependent glial uptake or chloride-dependent 
sequestration. 
Regional distribution 
Autoradiography of D-aspartate binding revealed a 
unique regional distribution. Binding in cerebellar molec- 
ular layer was 2- to 3-fold higher than in any region of 
forebrain. Within the forebrain, the distribution of 
binding sites was rather uniform. This pattern of binding 
is markedly different from the regional distribution of 
neuronal uptake sites determined in homogenates or 
fresh slices of forebrain 16'29-31'38. In contrast to the very 
high levels of o-aspartate binding found in the cerebellum 
in our autoradiographic assay, homogenate studies in rat, 
cat, and human brains have indicated that high-affinity 
neuronal uptake is higher in several regions of forebrain 
than in cerebellum 29'3°'38. The high levels of o-aspartate 
binding in cerebellum reported here are more reminis- 
cent of the glial uptake of o-aspartate reported in fresh 
slices of cerebellum 13'a6. Furthermore, the distinct lami- 
nar pattern of hippocampal neuronal uptake seen in fresh 
tissue slices 31 is different from the pattern of hippocampal 
D-aspartate binding reported here. In fresh slices of 
forebrain, the highest levels of cortical D-aspartate 
uptake are found in layer 116 . This is the cortical layer 
with the least D-aspartate binding. Thus, the anatomical 
pattern of o-aspartate binding sites is not consistent with 
the distribution of neuronal uptake sites described in 
several other studies. When glutamate binding is assayed 
in the presence of NaAc (with NMDA, quisqualate, and 
kainate to block binding to receptors), an identical 
pattern is produced. 
Synaptic localization 
Cortical afferents to striatum are believed to be 
glutamatergic. The corticostriatal pathway is predomi- 
nantly ipsilateral with a small crossed component. One 
week after unilateral frontoparietal decortications, sev- 
eral laboratories have demonstrated a marked decrease 
in striatal synaptosomal L-glutamate or o-aspartate up- 
take ipsilateral to the l e s i o n  17'33'34. Following identical 
lesions, we were unable to demonstrate any change in the 
affinity or number of D-aspartate binding sites in striatum 
ipsilateral to the lesion. Because of the small crossed 
corticostriatal projection, our use of the contralateral 
striatum as a control after decortication may have 
resulted in a slight underestimation of any subsequent 
changes in binding. However, similar use of the contra- 
lateral striatum as a control still results in a large decrease 
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in synaptosomal uptake ipsilateral to the lesion 33'34. The 
fact that D-aspartate binding was not reduced ipsilateral 
to the lesion suggests that the sites are not located on 
lesioned corticostriatal glutamatergic terminals. Alterna- 
tively, uptake carrier proteins capable of binding D- 
aspartate might persist in striatum, even after degener- 
ation of afferent terminals. In similar fashion, binding to 
NMDA, quisqualate and kainate receptors, as well as to 
glutamate binding sites in the presence of NaCl or NaAc 
was also unchanged by decortication. 
After a unilateral quinolinate lesion of the intrinsic 
neurons of the striatum, NMDA, quisqualate and kainate 
receptor binding was reduced by 80-90%, consistent with 
a postsynaptic localization of these receptors. In contrast, 
o-aspartate binding was not decreased in the region of 
the lesion in adjacent tissue sections. L-Glutamate bind- 
ing in the presence of NaAc, NMDA, quisqualate, and 
kainate also showed no changes in the lesion. L-Gluta- 
mate binding in the presence of NaCl, without receptor- 
specific blocking agents, was reduced by an intermediate 
amount (60%). These results strongly suggest that so- 
dium-dependent o-aspartate binding sites are not located 
on intrinsic neurons of the striatum. 
If these binding sites are not localized to afferent 
terminals or intrinsic neurons in the striatum, it must 
tentatively be concluded that o-aspartate binding sites are 
located on glia. The intermediate reduction in glutamate 
binding when assayed in the presence of NaCl, without 
agents to block binding to receptors, suggests that under 
these conditions, glutamate is binding to both receptors 
and the glial site. This is consistent with the report by 
Vincent and McGeer 32 that about half of the sodium- 
dependent glutamate binding sites in striatal membrane 
preparations are not associated with lesioned glutamat- 
ergic afferent terminals. 
Relationship of o-aspartate binding to neuronal uptake 
The results of this study suggest that sodium-depen- 
dent o-aspartate binding has several characteristics ex- 
pected of presynaptic neuronal uptake. Binding is en- 
tirely sodium-dependent, it is inhibited by glutamate and 
D,L-threo-hydroxyaspartic acid, and it has an affinity 
consistent with the neuronal uptake site. However, the 
regional distribution of this binding site is not consistent 
with previously described neuronal uptake sites. Further- 
more, the effects of lesions indicate that this site is not 
localized on pre- or postsynaptic neuronal elements. 
Together with evidence from homogenate experiments 
that a large portion of sodium-dependent L-glutamate 
binding is postsynaptic and that o-aspartate binding 
represents sequestration, the current autoradiographic 
study suggests that sodium-dependent D-aspartate bind- 
ing is a poor measure of presynaptic neuronal uptake 
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sites. Previous  studies using h o m o g e n a t e  or  au torad io-  
graphic  p repa ra t ions  should be in te rp re ted  with ex t reme 
cau t ion  and  their  conclus ions  reassessed.  
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